Rating History for Idera Pharmaceuticals (IDRA) by Wedbush
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/19/2021 | Robert Driscoll | Downgrade | Neutral (Outperform) |
N/A (N/A) |
5.21 (0.43) |
-91.75% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/19/2021 | Robert Driscoll | Downgrade | Neutral (Outperform) |
N/A (N/A) |
5.21 (0.43) |
-91.75% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||